 Anti-Asthmatic Agents
"Anti-Asthmatic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that are used to treat asthma.
| Descriptor ID |
D018927
|
| MeSH Number(s) |
D27.505.954.796.050
|
| Concept/Terms |
Anti-Asthmatic Agents- Anti-Asthmatic Agents
- Agents, Anti-Asthmatic
- Anti Asthmatic Agents
- Anti-Asthmatics
- Anti Asthmatics
- Antiasthmatic Drugs
- Drugs, Antiasthmatic
- Antiasthmatics
- Anti-Asthmatic Drugs
- Anti Asthmatic Drugs
- Drugs, Anti-Asthmatic
- Antiasthmatic Agents
- Agents, Antiasthmatic
|
Below are MeSH descriptors whose meaning is more general than "Anti-Asthmatic Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Asthmatic Agents".
This graph shows the total number of publications written about "Anti-Asthmatic Agents" by people in this website by year, and whether "Anti-Asthmatic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 | | 1996 | 2 | 1 | 3 | | 1997 | 4 | 0 | 4 | | 1998 | 5 | 0 | 5 | | 1999 | 4 | 1 | 5 | | 2000 | 4 | 2 | 6 | | 2001 | 2 | 0 | 2 | | 2002 | 6 | 0 | 6 | | 2003 | 8 | 1 | 9 | | 2004 | 5 | 3 | 8 | | 2005 | 5 | 5 | 10 | | 2006 | 6 | 3 | 9 | | 2007 | 5 | 3 | 8 | | 2008 | 7 | 8 | 15 | | 2009 | 5 | 4 | 9 | | 2010 | 6 | 4 | 10 | | 2011 | 7 | 5 | 12 | | 2012 | 3 | 5 | 8 | | 2013 | 7 | 2 | 9 | | 2014 | 3 | 2 | 5 | | 2015 | 10 | 3 | 13 | | 2016 | 12 | 7 | 19 | | 2017 | 11 | 4 | 15 | | 2018 | 13 | 5 | 18 | | 2019 | 10 | 0 | 10 | | 2020 | 13 | 3 | 16 | | 2021 | 12 | 1 | 13 | | 2022 | 12 | 0 | 12 | | 2023 | 10 | 0 | 10 | | 2024 | 10 | 8 | 18 | | 2025 | 4 | 0 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Anti-Asthmatic Agents" by people in Profiles.
-
Thomas D, Lewthwaite H, Gibson PG, Majellano E, Clark V, Fricker M, Hamada Y, Anderson GP, Backer V, Bardin P, Beasley R, Chien J, Farah CS, Harrington J, Harvey E, Hew M, Holland AE, Jenkins C, Katelaris CH, Katsoulotos G, Murray K, Peters M, Thomas R, Tonga K, Upham JW, Wark P, McDonald VM. Unlocking Asthma Remission: Key Insights From an Expert Roundtable Discussion. Respirology. 2025 Jun; 30(6):466-479.
-
Hamada Y, Thomas D, Harvey ES, Stevens S, Fricker M, Lewthwaite H, McDonald VM, Gillman A, Hew M, Kritikos V, Upham JW, Gibson PG. Distinct trajectories of treatment response to mepolizumab toward remission in patients with severe eosinophilic asthma. Eur Respir J. 2025 Jan; 65(1).
-
Rayner DG, Ferri DM, Guyatt GH, O'Byrne PM, Brignardello-Petersen R, Foroutan F, Chipps B, Sumino K, Perry TT, Nyenhuis S, Oppenheimer J, Israel E, Hoyte F, Rivera-Spoljaric K, McCabe E, Rangel S, Shade LE, Press VG, Hall L, Sue-Wah-Sing D, Melendez A, Orr H, Winders T, Gardner DD, Przywara K, Rank MA, Bacharier LB, Mosnaim G, Chu DK. Inhaled Reliever Therapies for Asthma: A Systematic Review and Meta-Analysis. JAMA. 2025 01 14; 333(2):143-152.
-
Szefler S, Corren J, Silverberg JI, Okragly A, Sun Z, Natalie CR, Zitnik R, Siu K, Blauvelt A. Lebrikizumab decreases type 2 inflammatory biomarker levels in patients with asthma: data from randomized phase 3 trials (LAVOLTA I and II). Immunotherapy. 2024; 16(20-22):1211-1216.
-
Callen E, Israel E, Cardet JC, Fuhlbrigge AL, Manning B, Gaona G, Staton E, Pace WD. Electronic health record data analysis on the impact of rescue-triggered inhaled corticosteroids on controller therapy in Black and Latinx individuals from a pragmatic, open-label, patient-level randomised trial. BMJ Open. 2024 Nov 21; 14(11):e088349.
-
Althoff MD, Gaietto K, Holguin F, Forno E. Obesity-related Asthma: A Pathobiology-based Overview of Existing and Emerging Treatment Approaches. Am J Respir Crit Care Med. 2024 Nov 15; 210(10):1186-1200.
-
Hamada Y, Gibson PG, Harvey ES, Stevens S, Lewthwaite H, Fricker M, McDonald VM, Gillman A, Hew M, Kritikos V, Upham JW, Thomas D. Early Treatment Response to Mepolizumab Predicts Clinical Remission in Severe Eosinophilic Asthma. J Allergy Clin Immunol Pract. 2025 Feb; 13(2):333-342.e9.
-
G?mez LF, Kinnee E, Kaufman JD, Young MT, Fitzpatrick AM, Phipatanakul W, Mauger DT, McClure LA, Bilal U, Holguin F, Clougherty JE. Modification of asthma treatment efficacy by healthcare access: A reanalysis of AsthmaNet Step-Up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations (STICS) clinical trial. Respir Med. 2024 Nov-Dec; 234:107853.
-
Pavord ID, Rabe KF, Israel E, Szefler SJ, Brusselle G, Pandit-Abid N, Altincatal A, Chen Z, Amin N, Khan AH, Lederer DJ, Zhang Y, Rowe PJ, Deniz Y, Radwan A, Jacob-Nara JA, Busse WW. Dupilumab Induces Long-Term On-Treatment Clinical Remission in Patients With Type 2 Asthma. J Allergy Clin Immunol Pract. 2025 Jan; 13(1):132-142.
-
Navanandan N, Jackson ND, Hamlington KL, Everman JL, Pruesse E, Secor EA, Stewart Z, Diener K, Hardee I, Edid A, Sulbaran H, Mistry RD, Florin TA, Yoder AC, Moore CM, Szefler SJ, Liu AH, Seibold MA. Viral Determinants of Childhood Asthma Exacerbation Severity and Treatment Response. J Allergy Clin Immunol Pract. 2025 Jan; 13(1):95-104.e5.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|